Bioresorbable Polymers Market

Report Code CH 4342
Published in Nov, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Bioresorbable Polymers Market by Type (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polylactic-co-glycolic acid (PLGA), Polycaprolactone) PCL), Application (Orthopedic Devices, Drug Delivery), and Region - Global Forecast to 2029

Overview

The global bioresorbable polymers market is valued at USD 500.0 million in 2024 and is projected to reach USD 867.2 million by 2029, growing at 11.6% cagr from 2024 to 2029. The orthopedic devices sector plays a significant role in the market for bioresorbable polymers, with a constant demand for materials that provide support for healing without the need for a second surgical intervention. Bioresorbable polymers such as PLA and PGA are utilized in screws, pins, and plates, and this is the largest benefit of the implants, in that they naturally degrade inside the body; thus, long-term complications, including stress shielding and infection, are minimized. Continuous developments in polymer technologies have increased the strength, degradation rates, and biocompatibility, and advances have accelerated their use in orthopedics due to the support for the market shift toward safer and more efficient patient-centric solutions.

Attractive Opportunities in the Bioresorbable Polymers Market

Asia Pacific

Market growth can be attributed to the strong healthcare industry in the region.

Rising demand from orthopedic devices sector is driving the global bioresorbable polymers market.

Mergers & acquisitions is expected to offer lucrative opportunities for market players in the next 5 years.

Asia Pacific is expected to be the highest growing market for bioresorbable polymers during the forecast period.

Market growth in Asia Pacific can be attributed to the growing geriatric population and investments in healthcare industry in emerging economies.

Global Bioresorbable Polymers Market Dynamics

Driver: Increasing number of surgical interventions

The World Bank Group predicts that in 2030, the number of surgeries worldwide is expected to reach 5,000 surgeries for every 100,000 people on an annual basis, dominated by road traffic injuries. Recently obtained WHO 2023 statistics indicate that every year across the globe, approximately 1.2 million people die due to road traffic accidents; however, between 20 to 50 million people also sustain non-fatal types of injuries that need surgical attention. Adults aged 65 years and above have a higher burden of chronic diseases, which is another factor for the increase in the number of surgical procedures performed. In both, emerging and developed economies, NCDs (Noncommunicable Diseases) represent over 87% of the disease burden. Alongside this, there has been an increase in the number of people seeking plastic and dental procedures, which is further creating demand for bioresorbable medical devices.

Restraints: Increasing preference for minimally invasive surgeries

The preference for minimally invasive surgeries is increasing due to the associated benefits, which include short stays in hospitals, faster recovery, minimal bleeding and pain. However, this shift in preference toward more minimally invasive procedures as opposed to the conventional mode of surgery has also resulted in the reduced demand for different kinds of medical devices, thereby limiting the growth of the market.

Laparoscopy is considered one of the most popular forms of minimally invasive surgeries in which several tiny incisions of 0.5-1.5 cm are made in the abdomen or pelvic area. This eliminates the need for a high number of stitches, which, in turn, reduces the demand for surgical sutures and decreases the consumption of bioresorbable polymers used in these sutures.

 

Opportunities: Electrospinning and 3D printing technology

Bioresorbable polymers, particularly in the case of electrospinning combined with 3D printing, are improving scaffold fabrication in tissue engineering in that scaffolds are more biocompatible and supportive to cells. Electrospinning produces thin fibrous elements representing the structure of the natural extracellular matrix (ECM) in order to enhance the cell attachment and growth required for the formation of the desired tissue. 3D printing also makes it possible to produce scaffolds as per specific patient needs, optimized according to the required dimensions, configurations, and biodegradation rates, which are important for regenerative medicine. The architecture of the detailed scaffold design enhances the tissue integration capacity, more so in the repair of bone and soft tissues. Because these polymers are designed to erode away in the body, the chances of the patient undergoing a removal surgery are significantly reduced, thus breathing new life into personalized medicine and creative treatment approaches.

Challenges: Stringent regulatory framework for medical devices

The innovation of bioresorbable medical devices is an expensive exercise, usually requiring more than 7–8 years to get the product on the market. In the US, for instance, the FDA requires manufacturers of bioabsorbable devices to obtain a Premarket Approval (PMA), which has several filing requirements and clinical trial data to be submitted with the filing. Developmental costs and high risks prohibit more than two-thirds of the products from ever advancing into the clinical trial stages. The burden of acquiring clinically meaningful trial data is also high. Smart polymers, which are bioresorbable, are considered Class II devices, and regulatory constraints impose a major bottleneck in the development and market entry of new bioresorbable polymers.

Global Bioresorbable Polymers Market Ecosystem Analysis

Prominent companies in this market include well-established, financially stable manufacturers of bioresorbable polymers. These companies have been in business for a while and have broad product portfolios, cutting-edge technologies, and wide international sales and marketing networks. Prominent companies in this market include Corbion (Netherlands), Evonik Industries AG (Germany), Foster Corporation (US), KLS Martin Group (Germany), DSM Biomedical (US), Ashland Global Holdings Inc. (US), Zeus Company LLC (US), Seqens (France), Reva Medical, LLC (US), and Poly-Med Incorporated (US).

 

Based on type, PLGA to be fastest-growing segment in bioresorbable polymers market during forecast period

PLGA (polylactic-co-glycolic acid) bioresorbable polymer has the highest demand in the market, primarily due to the wide range of applications, biocompatibility, and controlled degradation. The degradation time period of PLGA can be engineered by changing its lactic and glycolic acid ratio, allowing it to serve a multitude of medical purposes, from drug delivery systems to tissue engineering and surgical sutures. PLGA’s affordability, coupled with its FDA-approved use for various applications encourages its multifunctional utilization as it ensures safety and efficacy even under the strictest measures. The extensive use of PLGA in regenerative medicine and implants also favors its growth in the healthcare market due to the rising demand for advanced bioresorbable products.

Based on end-use industry, drug delivery to be fastest-growing segment in bioresorbable polymers market during forecast period

Among all existing applications of bioresorbable polymers, the drug delivery segment is projected to grow at the highest rate. Controlled drug release helps improve the effectiveness of treatment and patient compliance. These polymers have a gradual bioavailability that does not need removal,, thus reducing the risk of post-treatment complications. This means that they absolutely fit uses in biomedical applications such as those dealing with cancer, where the slow and sustained delivery of drugs helps in achieving better results. Above all, recent improvements in the polymer technology enable controlled release and drug eluting kinetics. The need for efficient, precise, and least invasive delivery systems, which are being provided owing to the emerging trends are contributing to the growth of this segment.

In terms of CAGR, Asia Pacific to lead bioresorbable polymers market during the forecast period

In terms of revenue growth, the Asia Pacific region is poised to lead the bioresorbable polymers market. The rapid growth is attributed to the increase in healthcare spending, rise in the number of chronic diseases, and the growing need for advanced healthcare technologies. The expanding pharmaceutical and medical devices market, as well as rapid economic development in countries such as China, India, and Southeast Asian countries, is, however, crucial. In the region, patients are also becoming increasingly aware of minimally invasive surgeries as well as the benefits of bioresorbable polymers, such as low surgical complications and reduced length of stay in hospitals. Additional government backing in the form of policies, research funding, and investments in healthcare systems also enhance the growth of the market. Global and local manufacturers’ know-how and manufacturer exemptions also contribute to innovative developments and market expansion in the region.

HIGHEST CAGR MARKET IN 2024-2029
INDIA FASTEST GROWING MARKET IN THE REGION

Recent Developments of Bioresorbable Polymers Market

  • In August 2024, Ashland’s expanded Irish facility boosts bioresorbable polymer production, enhancing the production of the injectable technology to meet the rising demand for advanced pharmaceutical applications, including long-acting formulations, bioresorbable devices, and tissue engineering solutions.
  • In April 2024, Evonik expanded its RESOMER powder biomaterial production facility in Germany, adding the solvent-free micronization technology to offer customized medical powders for implants and esthetic applications.
  • In August 2021, Evonik acquired the German biotech JeNaCell, to expand its biomaterials portfolio, integrating innovative cellulose-based materials for wound care, dermatology, and medical technology into its Health Care division.
  • In September 2020, Corbion and Total announced building a new PLA bioplastics plant in Europe through their Total Corbion PLA joint venture. The plant is expected to have a capacity of 100,000 tons per annum, being the first global-scale PLA production facility in Europe. The new plant is planned to be located in France and be operational in 2024. This additional PLA investment is expected to accelerate plans to further expand the production of lactic acid.

Key Market Players

KEY PLAYERS IN THE BIORESORBABLE POLYMERS MARKET INCLUDE

Want to explore hidden markets that can drive new revenue in Bioresorbable Polymers Market?

Scope of the Report

Report Metric Details
Years considered for the study 2019-2029
Base Year Considered 2023
Forecast period 2024-2029
Units considered Value (USD Million) and Volume (Unit)
Segments covered Type, Application, and Region
Geographies covered Asia Pacific, Europe, North America, Middle East & Africa, and South America

Key Questions Addressed by the Report

Who are the major players in the bioresorbable polymers market?
The key players in this market include Corbion (Netherlands), Evonik Industries AG (Germany), Foster Corporation (US), KLS Martin Group (Germany), DSM Biomedical (US), Ashland Global Holdings Inc. (US), Zeus Company LLC (US), Seqens (France), Reva Medical, LLC (US), and Poly-Med Incorporated (US).
What are the drivers and opportunities for the bioresorbable polymers market?
The increasing number of surgical interventions is the major driver for the bioresorbable polymers market. Electrospinning and the 3D printing technology are expected to create new opportunities for the market.
Which strategies are the key players focusing upon in the bioresorbable polymers market?
Product launches, acquisitions, and expansions are some of the strategies adopted by the key players to expand their global presence.
What is expected to be the CAGR of the bioresorbable polymers market during the forecast period?
The market is projected to grow at a CAGR of 11.6% in terms of value during the forecast period.
Which major factors are expected to restrain the growth of the bioresorbable polymers market during the forecast period?
The increasing preference for minimally invasive surgeries is expected to restrict market growth during the forecast period.

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Bioresorbable Polymers Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
1
RESEARCH METHODOLOGY
17
EXECUTIVE SUMMARY
34
PREMIUM INSIGHTS
56
MARKET OVERVIEW
78
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    RESTRAINTS
    OPPORTUNITIES
    CHALLENGES
  • 5.3 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF BUYERS
    BARGAINING POWER OF SUPPLIERS
    DEGREE OF COMPETITIVE RIVALRY
  • 5.4 MACROECONOMIC OUTLOOK
    INTRODUCTION
    GDP TRENDS AND FORECAST
  • 5.5 VALUE/SUPPLY CHAIN ANALYSIS
    RAW MATERIALS
    MANUFACTURING
    DISTRIBUTION
    END-USE INDUSTRIES
  • 5.6 PRICING ANALYSIS
    AVERAGE SELLING PRICE TREND, BY REGION
    AVERAGE SELLING PRICE TREND, BY TYPE
    AVERAGE SELLING PRICE TREND, BY APPLICATION
    AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
  • 5.7 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA
  • 5.8 TRADE ANALYSIS
    EXPORT SCENARIO
    IMPORT SCENARIO
  • 5.9 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY FRAMEWORK
  • 5.10 ECOSYSTEM ANALYSIS/MARKET MAP
  • 5.11 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.12 INVESTMENT AND FUNDING SCENARIO
  • 5.13 PATENT ANALYSIS
    METHODOLOGY
    PUBLICATION TRENDS
    JURISDICTION ANALYSIS
    TOP APPLICANTS
    TOP PATENT OWNERS
  • 5.14 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Polymer Materials & Chemistry
    - Polymer Processing and Fabrication
    COMPLEMENTARY TECHNOLOGIES
    - Imaging and Monitoring
    ADJACENT TECHNOLOGIES
    - Regenerative Medicine and Tissue Engineering
    - Regenerative Medicine
  • 5.15 IMPACT OF AI/GEN AI ON BIORESORBABLE POLYMERS
  • 5.16 CASE STUDY ANALYSIS
  • 5.17 KEY CONFERENCES & EVENTS IN 2024-2025
BIORESORBABLE POLYMERS MARKET, BY TYPE
89
  • 6.1 INTRODUCTION
  • 6.2 POLYLACTIC ACID (PLA)
  • 6.3 POLYGLYCOLIC ACID (PGA)
  • 6.4 POLY (LACTIC-CO-GLYCOLIC ACID) (PLGA)
  • 6.5 POLYCAPROLACTONE (PCL)
  • 6.6 OTHERS
BIORESORBABLE POLYMERS MARKET, BY APPLICATION
110
  • 7.1 INTRODUCTION
  • 7.2 ORTHOPEDIC DEVICES
    TRAUMA
    HIP
    KNEE
    SPINE
    SPORTS INJURY
    OTHERS
  • 7.3 DRUG DELIVERY
    ORAL
    PARENTERAL
    OTHERS
  • 7.4 OTHERS
BIORESORBABLE POLYMERS MARKET, BY REGION
125
  • 8.1 INTRODUCTION
  • 8.2 EUROPE
    GERMANY
    RUSSIA
    FRANCE
    UK
    ITALY
    REST OF EUROPE
  • 8.3 ASIA PACIFIC
    CHINA
    INDIA
    JAPAN
    SOUTH KOREA
    REST OF ASIA PACIFIC
  • 8.4 NORTH AMERICA
    US
    CANADA
    MEXICO
  • 8.5 MIDDLE EAST & AFRICA
    MIDDLE EAST
    - GCC countries
    - Rest of Middle East
    AFRICA
  • 8.6 SOUTH AMERICA
    BRAZIL
    ARGENTINA
    REST OF THE SOUTH AMERICA
COMPETITIVE LANDSCAPE
145
  • 9.1 INTRODUCTION
  • 9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN (2020–2024)
    OVERVIEWS OF STRATEGIES ADOPTED BY KEY PLAYERS
  • 9.3 MARKET SHARE ANALYSIS (2023)
    MARKET RANKING ANALYSIS
  • 9.4 TOP 5 KEY PLAYERS REVENUE ANALYSIS
  • 9.5 COMPANY VALUATION AND FINANCIAL METRICS, 2023
    COMPANY VALUATION
    FINANCIAL METRICS
  • 9.6 BRAND/PRODUCT COMPARISON
  • 9.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS, 2023
    - Company Footprint
    - Region Footprint
    - Type Footprint
    - Application Footprint
  • 9.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
    - Detailed List of Key Startups/SMEs
    - Competitive Benchmarking of Key Startups/SMEs
  • 9.9 COMPETITIVE SCENARIO
    BIORESORBABLE POLYMERS: DEALS, (2020–2024)
    BIORESORBABLE POLYMERS: PRODUCT LAUNCHES, (2020–2024)
    BIORESORBABLE POLYMERS: INVESTMENTS & EXPANSIONS, (2020–2024)
    BIORESORBABLE POLYMERS: OTHER DEVELOPMENTS, (2020–2024)
COMPANY PROFILE
178
  • 10.1 KEY PLAYERS
    CORBION
    EVONIK INDUSTRIES AG
    FOSTER CORPORATION
    KLS MARTIN GROUP
    DSM BIOMEDICAL
    ASHLAND GLOBAL HOLDINGS INC.
    ZEUS COMPANY LLC
    SEQENS
    REVA MEDICAL, LLC
    POLY-MED INCORPORATED
  • 10.2 OTHER COMPANIES
    BEZWADA BIOMEDICAL, LLC
    NOMISHA HEALTHCARE PVT. LTD.
    BMG INC.
    POLYSCIENCES INC.
    HUIZHOU FORYOU MEDICAL DEVICES CO., LTD.
    MUSASHINO CHEMICAL LABORATORY, LTD.
    HENAN XINGHAN BIOMEDICAL TECHNOLOGY CO., LTD.
    OTHER COMPANIES
ADJACENT & RELATED MARKET
198
APPENDIX
135
  • 12.1 DISCUSSION GUIDE
  • 12.2 RELATED REPORTS

The study involved four major activities in estimating the market size for bioresorbable polymers market. Exhaustive secondary research was done to collect information on the market, the peer market, and the parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, the market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

Secondary sources used in this study included annual reports, press releases, and investor presentations of companies; white papers; certified publications; articles from recognized authors; and gold standard & silver standard websites such as Factiva, ICIS, Bloomberg, and others. The findings of this study were verified through primary research by conducting extensive interviews with key officials such as CEOs, VPs, directors, and other executives. The breakdown of profiles of the primary interviewees is illustrated in the figure below:

Primary Research

The bioresorbable polymers market comprises several stakeholders, such as raw material suppliers, end-product manufacturers, and regulatory organizations in the supply chain. The demand side of this market is characterized from key opinion leaders in various applications for the bioresorbable polymers market. The supply side is characterized by advancements in technology and diverse application industries. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information.

The following is a breakdown of the primary respondents:

Note: Tier 1, Tier 2, and Tier 3 companies are classified based on their market revenue in 2022/ 2023, available in the public domain, product portfolios, and geographical presence.

Other designations include consultants and sales, marketing, and procurement managers.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME DESIGNATION
Evonik Industries AG Sales Manager
Ashland Global Holdings Inc. R&D Manager
KLS Martin Group Global R&D Head
DSM Biomedical Business Development Manager
Poly-Med Incorporated Regional Sales Manager

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the bioresorbable polymers market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry have been identified through extensive secondary research.
  • The supply chain of the industry has been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
  • All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to obtain the final quantitative and qualitative data.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes as explained above—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the bioresorbable polymers industry.

Market Definition

The bioresorbable polymers are the type of polymers. They are designed to naturally degrade and be absorbed within biological environments. These polymers are utilized in medical and healthcare sectors, where they are used to manufacture orthopedic devices and drug delivery systems. The demand of bioresorbable polymers influenced by the innovation in medical devices and the need for the eco-friendly alternatives to the permanent implants. The key components of the bioresorbable polymers are PLA, PGA, PLGA, and PCL.

Stakeholders

  • Bioresorbable polymers manufacturers
  • Bioresorbable polymers suppliers
  • Raw material suppliers
  • Application sector companies
  • Government bodies

Report Objectives

  • To define, describe, and forecast the bioresorbable polymers market in terms of value and volume
  • To provide detailed information regarding the drivers, opportunities, restraints, and challenges influencing market growth
  • To estimate and forecast the market size by type, application, and region
  • To forecast the size of the market for five main regions: Asia Pacific, Europe, North America, South America, and the Middle East & Africa, along with their key countries
  • To strategically analyze micromarkets1 with respect to their growth trends, prospects, and contribution to the overall market
  • To analyze opportunities in the market for stakeholders and provide a competitive landscape for market leaders
  • To analyze competitive developments, such as deals and expansions, in the market
  • To strategically profile key players and comprehensively analyze their growth strategies

Previous Versions of this Report

Bioresorbable Polymers Market by Type (Polylactic acid (PLA), Polyglycolic acid (PGA), Polylactic-co-glycolic acid (PLGA), Polycaprolactone(PCL)), application (orthopedic devices, drug delivery), and Region - Global Forecast to 2027

Report Code CH 4342
Published in Jan, 2023, By MarketsandMarkets™

Bioresorbable Polymers Market by Type(Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly(lactic-co-glycolic Acid) (PLGA), Polycaprolactone(PCL)), Application (Orthopedic Devices, Drug Delivery), and Region - Global Forecast to 2026

Report Code CH 4342
Published in Nov, 2021, By MarketsandMarkets™

Bioresorbable Polymers Market by Type(Polylactic Acid (PLA), Polyglycolic Acid (PGA), Poly(lactic-co-glycolic Acid) (PLGA), Polycaprolactone(PCL)), Application (Orthopedic Devices, Drug Delivery), and Region - Global Forecast to 2026

Report Code CH 4342
Published in May, 2016, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Bioresorbable Polymers Market

DMCA.com Protection Status